Aligos Therapeutics GAAP EPS of -$2.09 beats by $0.19, revenue of $2.83M misses by $2.71M

Read Aligos Therapeutics' Q3 results: EPS beat estimates, revenue missed, and key takeaways for investors tracking biotech earnings now.